Skip to content

Evaluation of the cardiovascular effects of Medicinal Cannabis

Effects of Medicinal Cannabis on hemodynamics, on the nervous system autonomous and peripheral microcirculation of humans

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-9grvg8d
Enrollment
Unknown
Registered
2024-08-15
Start date
2024-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Interventions

The present study aims to analyze cardiovascular parameters of patients in medical cannabis clinics. It is a longitudinal and cross-sectional observational clinical research, according to the intrinsi
C14.907.474
E01.370.370.585

Sponsors

Hospital de Clínicas da Universidade Federal do Paraná
Lead Sponsor
Hospital de Clínicas da Universidade Federal do Paraná
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: adults of both sexes; older than 18 years old; be a patient at cannabis clinics medicine or the Basic Unit of Health; for the treatment group, carry out medical cannabis treatment on a continuous basis

Exclusion criteria

Exclusion criteria: patients with heart failure; patients with valvular heart disease; patients with infectious endocarditis; patients with peripheral arterial disease serious; patients on hemodialysis with fistula arteriovenous; patients with cardiac arrhythmias; patients with coronary disease ischemic (history of Acute Myocardial Infarction AMI) Systemic sclerosis; any decompensated chronic disease;history of syncope and collapse; pregnant women

Design outcomes

Primary

MeasureTime frame
Assessment of Heart Rate Variability characteristics between treatment groups and control groups, according to time-domain and non-linear results analysis parameters;Assessment of the minimum, maximum and average values ??of the Peripheral Perfusion Index between treatment groups and control groups, according to the analysis of its variation over time;Assessment of the minimum, maximum and average Heart Rate values ??between treatment groups and control groups, according to the analysis of its variation over time;Assessment of the minimum, maximum and average Blood Pressure values ??between treatment groups and control groups, according to the analysis of its variation over time;Assessment of the minimum, maximum and average values ??of Oxygen Saturation between treatment groups and control groups, according to the analysis of its variation over time

Secondary

MeasureTime frame
Possible correlations between Heart Rate Variability and demographic data;Possible correlations between Peripheral Perfusion Index and demographic data;Possible correlations between Heart Rate and demographic data;Possible correlations between Blood Pressure and demographic data;Possible correlations between Oxygen Saturation and demographic data

Countries

Brazil

Contacts

Public ContactAlan Kornin

Hospital de Clínicas da Universidade Federal do Paraná

alankornin@gmail.com+55 (11) 947954591

Outcome results

None listed

Source: REBEC (via WHO ICTRP)